BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  AVACEN Medical Announces Autism Clinical Trial

  Avacen Medical announced it will be using Crowdfunder.com to fund a double-blind, randomized, placebo-controlled clinical study in the first quarter of 2018 using the AVACEN 100 for autism behavior treatment.

  December 29, 2017

   · 

  4 min read
• Biocon and Mylan’s Biosimilar Trastuzumab Receives Approval From ANVISA, Brazil Through Their Partner Libbs

  Libbs will commercialize the product in Brazil under the brand name Zedora, which will provide affordable access to a cutting-edge biologics therapy for patients in Brazil.

  December 29, 2017

   · 

  9 min read
• Pharm Country

  Brainstorm Issues 2017 Letter to Shareholders

  BrainStorm today issued a Letter to Shareholders from its President and CEO, Chaim Lebovits

  December 29, 2017

   · 

  4 min read
• Biotech Bay

  Leonhardt’s Launchpads Organ Regeneration Technology Showcase January 8th San Francisco

  Today Leonhardt’s Launchpads, an innovation accelerator focused on organ regeneration technologies, announced a technology showcase Monday January 8th, 2018 at WeWork SoMa, 156 2nd St, San Francisco, CA 94105 @ 5pm to 6:30pm.

  December 29, 2017

   · 

  8 min read
• Policy

  CStone’s Anti-CTLA-4 Antibody CS1002 Filed for Clinical Trial Approval in Australia

  The application represents CStone’s third molecule to be submitted for clinical trial approval overseas during 2017.

  December 29, 2017

   · 

  3 min read